基本信息
浏览量:2
职业迁徙
个人简介
Paul Farrell's research is mostly on mechanisms by which the human tumour virus Epstein-Barr Virus causes human cells to proliferate and the role of the virus in human cancers.
Epstein-Barr virus is a human herpesvirus that infects most people in the world early in life and then persists life-long. Primary EBV infection that is delayed until adolescence or adulthood frequently causes infectious mononucleosis (glandular fever). Most carriers of EBV show no symptoms or pathology but in some circumstances EBV is associated with human cancers, the virus normally being present in all of the tumour cells of an EBV associated case. These cancers include lymphomas in immunosuppressed people (either as a result of medication after transplant surgery or AIDS), Hodgkin's disease, Burkitt's lymphoma in central Africa, nasopharyngeal carcinoma in South-East Asia and some gastric carcinomas. EBV infects human B lymphocytes and certain epithelial cells; infection of lymphocytes is readily accomplished in the laboratory and EBV drives the cells into a state of permanent proliferation.
Paul Farrell acted as Head of Molecular Virology at Imperial College 1996-2000 and 2011-2018. He was also Director of the London St Mary's branch of the Ludwig Institute for Cancer Research 1986-2005, at the same location. From 2009 - 2016 he chaired the Research Grants committee for the Leukaemia and Lymphoma Research charity (now called Blood Cancer UK) and he has served on numerous international advisory and review committees.
Current research is focussed on
Superior B cell transformation by type 1 EBV
Worldwide EBV sequence variation in relation to EBV diseases
Roles of RUNX genes in human B cells
Epstein-Barr virus is a human herpesvirus that infects most people in the world early in life and then persists life-long. Primary EBV infection that is delayed until adolescence or adulthood frequently causes infectious mononucleosis (glandular fever). Most carriers of EBV show no symptoms or pathology but in some circumstances EBV is associated with human cancers, the virus normally being present in all of the tumour cells of an EBV associated case. These cancers include lymphomas in immunosuppressed people (either as a result of medication after transplant surgery or AIDS), Hodgkin's disease, Burkitt's lymphoma in central Africa, nasopharyngeal carcinoma in South-East Asia and some gastric carcinomas. EBV infects human B lymphocytes and certain epithelial cells; infection of lymphocytes is readily accomplished in the laboratory and EBV drives the cells into a state of permanent proliferation.
Paul Farrell acted as Head of Molecular Virology at Imperial College 1996-2000 and 2011-2018. He was also Director of the London St Mary's branch of the Ludwig Institute for Cancer Research 1986-2005, at the same location. From 2009 - 2016 he chaired the Research Grants committee for the Leukaemia and Lymphoma Research charity (now called Blood Cancer UK) and he has served on numerous international advisory and review committees.
Current research is focussed on
Superior B cell transformation by type 1 EBV
Worldwide EBV sequence variation in relation to EBV diseases
Roles of RUNX genes in human B cells
研究兴趣
论文共 131 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CELLno. 26 (2023): 5675-5676
Robert Paganelli,Paul Farrell
crossref(2022)
Nature communicationsno. 1 (2021): 512-11
British journal of haematologyno. 2 (2021): 249-255
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn